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A B S T R A C T
Psychosocial stress is a major risk factor for depression, stress leads to peripheral and central immune activation,
immune activation is associated with blunted dopamine (DA) neural function, DA function underlies reward
interest, and reduced reward interest is a core symptom of depression. These states might be inter-independent
in a complex causal pathway. Whilst animal-model evidence exists for some speciﬁc steps in the pathway, there
is currently no animal model in which it has been demonstrated that social stress leads to each of these immune,
neural and behavioural states. Such a model would provide important existential evidence for the complex
pathway and would enable the study of causality and mediating mechanisms at speciﬁc steps in the pathway.
Therefore, in the present mouse study we investigated for eﬀects of 15-day resident-intruder chronic social stress
(CSS) on each of these states. Relative to controls, CSS mice exhibited higher spleen levels of granulocytes,
inﬂammatory monocytes and T helper 17 cells; plasma levels of inducible nitric oxide synthase; and liver ex-
pression of genes encoding kynurenine pathway enzymes. CSS led in the ventral tegmental area to higher levels
of kynurenine and the microglia markers Iba1 and Cd11b and higher binding activity of DA D1 receptor; and in
the nucleus accumbens (NAcc) to higher kynurenine, lower DA turnover and lower c-fos expression.
Pharmacological challenge with DA reuptake inhibitor identiﬁed attenuation of DA stimulatory eﬀects on lo-
comotor activity and NAcc c-fos expression in CSS mice. In behavioural tests of operant responding for sucrose
reward validated as sensitive assays for NAcc DA function, CSS mice exhibited less reward-directed behaviour.
Therefore, this mouse study demonstrates that a chronic social stressor leads to changes in each of the immune,
neural and behavioural states proposed to mediate between stress and disruption of DA-dependent reward
processing. The model can now be applied to investigate causality and, if demonstrated, underlying mechanisms
in speciﬁc steps of this immune-neural-behavioural pathway, and thereby to identify potential therapeutic
targets.
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1. Introduction
Stress-related neuropsychiatric disorders often present with psy-
chopathology of reward processing. Depression is a prevalent example,
with a core symptom being reduced interest in reward (DSM-5 2013;
Pizzagalli, 2014). Within the research domain criteria (RDoC) frame-
work, Positive valence systems is the domain that includes dimensions
of reward processing (Cuthbert and Insel, 2013). Reward valuation
including under eﬀortful conditions (Sherdell et al., 2012; Treadway
et al., 2012), and stimulus-reward learning and expectancy (Pizzagalli
et al., 2005), are examples of positive valence dimensions that can be
pathological in depression. Deﬁcient reward processing co-occurs with
reduced activation of the striatum, in particular the nucleus accumbens
(NAcc) (Arrondo et al., 2015). The NAcc receives dopamine (DA) inputs
from cell bodies in the ventral tegmental area (VTA) and this is a major
pathway in the mesolimbic DA neural circuit of reward processing
(Pizzagalli, 2014). Rodent studies have demonstrated the importance of
the VTA-NAcc DA pathway in regulating reward-directed behaviour,
including approach motivation, reward valuation and reward ex-
pectancy (Bergamini et al., 2016b; Russo and Nestler, 2013; Salamone
et al., 2015). Whilst it is often proposed that pathology in this pathway
underlies impaired reward processing in depression (Dunlop and
Nemeroﬀ, 2007; Pizzagalli, 2014), the responsible aetio-pathophysio-
logical mechanisms are poorly understood.
Stressful environmental life events are major aetiological factors in
depression, with uncontrollable psychosocial stressors conferring par-
ticularly high risk to trigger and maintain episodes (Kendler et al.,
1999; Slavich et al., 2009). Animal models allow for the causal study of
eﬀects of environmental stressors on brain and behaviour. In mice, the
resident-intruder paradigm is used to induce social stress and has been
applied in various forms, including repeated social defeat (RSD)
(Wohleb et al., 2011), chronic social defeat (CSD) (Krishnan et al.,
2007) and chronic social stress (CSS) (Azzinnari et al., 2014). In these
paradigms, mice are exposed to chronic, uncontrollable social stress
(Azzinnari et al., 2014; Kudryavtseva et al., 1991). CSS involves placing
the subject mouse with an aggressive resident mouse for a brief period
of attack without injury followed by continuous distal exposure, and
repeating this with a diﬀerent resident across 15 days. Behavioural
eﬀects of these stressors include increased anxiety (RSD: (Wohleb et al.,
2011), CSD (Krishnan et al., 2007)), increased aversion sensitivity,
decreased aversion control, increased fatigue (CSS (Azzinnari et al.,
2014; Fuertig et al., 2016)), decreased sensitivity to gustatory reward
(CSD (Krishnan et al., 2007)), decreased eﬀortful valuation of gustatory
reward and decreased reward expectancy (CSS (Bergamini et al.,
2016a)).
There is human and animal evidence that stressors activate the
immune-inﬂammatory system, with noradrenaline released from the
sympathetic branch of the autonomic nervous system binding to nora-
drenergic receptors on myeloid cells in the spleen and other immune
tissues being a major brain-periphery mediator (Bierhaus et al., 2003;
Johnson et al., 2005; Wohleb et al., 2011). In healthy humans, acute
psychosocial stress increases blood levels of proinﬂammatory chemo-
kines and cytokines (Bierhaus et al., 2003). Chronic social stress is as-
sociated with increased blood levels of C-reactive protein (CRP), in-
terleukin (IL)-6 and soluble receptor for tumor necrosis factor-α (TNF-
α) (Chiang et al., 2012; Gruenewald et al., 2009), and is proposed to
lead to low-grade systemic inﬂammation (Rohleder, 2014). Turning to
depression, there is substantive evidence for immune activation, in-
cluding higher blood levels of inﬂammatory markers such as CRP, IL-6,
IL-1 and TNF-α (Dowlati et al., 2010) and also of T-cell activation
markers (Maes, 2010). One down-stream eﬀect of higher proin-
ﬂammatory cytokines is activation of the kynurenine pathway of
tryptophan metabolism (Campbell et al., 2014; Haroon et al., 2012;
Schwarcz et al., 2012), for which there is also evidence in depression
(Savitz et al., 2015a, 2015b; Steiner et al., 2011; Sublette et al., 2011).
Kynurenine metabolites include 3-hydroxykynurenine (3-HK), a free
radical generator that promotes oxidative stress (Schwarcz et al., 2012),
and quinolinic acid, a glutamate receptor agonist and neurotoxin
(Dantzer and Walker, 2014). In mice, the stressors RSD, CSD and CSS
induce higher blood levels of some proinﬂammatory cytokines (e.g.
TNF-α, IFN-γ) and splenomegaly (Azzinnari et al., 2014; Fuertig et al.,
2016; Savignac et al., 2011; Wohleb et al., 2014). Mouse CSS increases
kynurenine pathway activity in the blood and in prefrontal cortex,
amygdala and hippocampus (Fuertig et al., 2016), whilst RSD induces
brain traﬃcking of myeloid cells as well as microglial activation in
these same brain regions (Wohleb et al., 2011, 2013).
With regard to immune activation impacting on DA-modulated be-
havioural processes, in depressed patients, plasma levels of CRP and
inﬂammatory cytokines correlated negatively with resting-state func-
tional connectivity between ventral striatum (NAcc) and prefrontal
cortex, reward sensitivity, and psychomotor function (Felger et al.,
2016; Goldsmith et al., 2016). In patients treated chronically with IFN-
α for hepatitis C or malignant melanoma, 50% met criteria for de-
pression; activation of ventral striatum in response to reward was re-
duced, and symptoms included reduced reward sensitivity, as well as
motor slowing and fatigue (Capuron et al., 2012). Acute administration
of lipopolysaccharide (LPS) to healthy volunteers reduces ventral
striatum response to reward (Eisenberger et al., 2010; Harrison et al.,
2016). In monkeys, chronic IFN-α led to less eﬀortful responding for
sucrose and attenuated stimulated DA release in the striatum (Felger
et al., 2013). In rodents, acute inﬂammatory challenge, e.g. IL-1β, LPS,
CD40 agonist antibody, induces sickness followed by a period of re-
duced preference, consumption and eﬀortful responding for sucrose
(Cathomas et al., 2015; Nunes et al., 2014; Vichaya et al., 2014). These
inﬂammatory factors induce post-sickness reduced DA synthesis and
release (Kitagami et al., 2003; Reinert et al., 2014). Finally, CSD has
been reported to increase VTA microglia activation and decrease NAcc
DA turnover (Tanaka et al., 2012).
Given the above evidence, it would clearly be important to identify
an animal model in which chronic social stress leads to the constellation
of: immune-inﬂammatory activation in the periphery, immune activa-
tion in the VTA-NAcc DA pathway, reduced VTA-NAcc DA pathway
functioning, and reduced NAcc DA-dependent reward-directed beha-
viour. This model could then be utilised to investigate cause-eﬀect
pathophysiological mechanisms at the various interfaces, with the aim
of identifying potential targets for treatment of reward-related psy-
chopathologies. Here we report on such a model in mice.
2. Materials and methods
2.1. Animals and housing
Breeding of C57BL/6J mice was conducted in-house. For all ex-
periments, breeding pairs contributed either 1 or 2 oﬀspring to the CSS
and/or CON group. Male oﬀspring were weaned at age 4 weeks and
caged in groups of 2–3 littermates. Mice were aged 10–13 weeks and
weighed 24.0–30.0 g at study onset. Male CD-1 mice (Janvier, Saint-
Berthevin, France) were aged 8 months, were ex-breeders, and caged
singly at study onset. Mice were maintained on a reversed 12:12 h light-
dark cycle (lights oﬀ 07:00–19:00 h) in an individually-ventilated ca-
ging system at 21–22 °C and 50–60% humidity. Complete-pellet diet
(Provimi, Kliba Ltd, Kaiseraugst, Switzerland) and water were available
ad libitum, unless stated otherwise below for operant training and
testing. All procedures were conducted during the dark phase of the
cycle. The study was conducted under permits for animal experi-
mentation (170/2012, 149/2015) issued by the Veterinary Oﬃce of
canton Zurich in accordance with the regulations of the Swiss Federal
Veterinary Oﬃce. All eﬀorts were made to minimize the number of
mice studied and any unnecessary stress.
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2.2. Experimental design
Ten experiments were conducted with C57BL/6J male mice. Each
experiment investigated the eﬀect of CSS relative to control handling on
immune cells/inﬂammation status or DA function or behaviour, except
one experiment which provided data on immune cells and DA function
from the same mice. This overall design provided data on diﬀerent
measures for the same brain region, and avoided any confound of
procedures required for behavioural experiments on immune or DA
function. The design of each experiment (Expt) is presented in Fig. S1.
In each of Expts 1–9 a motor activity test in a novel arena was con-
ducted and total activity was used to counterbalance allocation of mice
to CSS and CON groups (Azzinnari et al., 2014). In Expt 1, CSS eﬀects
on spleen and whole brain immune-cell status were assessed using ﬂow
cytometry. In Expt 2, liver gene expression for kynurenine pathway
enzymes was measured using qPCR, and plasma inducible nitric oxide
synthase (iNOS) was measured in ELISA. In Expt 3, im-
munohistochemistry of the microglia marker ionized calcium-binding
adapter molecule 1 (Iba1) in VTA and NAcc was conducted. In Expt 4,
VTA expression of the microglia marker gene Cd11b and of genes en-
coding DA synthesis and transport proteins was measured using RT
qPCR. In Expt 5, tissue level of kynurenine pathway metabolites was
determined in VTA and NAcc using LC-MS/MS. In Expt 6, VTA and
NAcc binding of DA D1 and D2 receptors was determined using quan-
titative autoradiography. In Expt 7, NAcc tissue level of DA and its
major metabolites were measured using HPLC-ED. In Expt 8, CSS eﬀects
on responsiveness to DA reuptake inhibitor challenge were assessed in
terms of an activity test, home-cage activity, and NAcc immediate-early
gene expression. In Expt 9, reward consumption under freely available
conditions was assessed using a two-bottle saccharin versus water test.
In Expt 10, mice were trained in an operant apparatus with sucrose
reinforcement, followed by measurement of reward-directed behaviour
in operant tests.
2.3. Chronic social stress
Chronic social stress (CSS) was conducted as described in detail
previously (Azzinnari et al., 2014). Brieﬂy, the home cages of ag-
gressive CD-1 mice were divided by a transparent, perforated divider. A
CSS mouse was placed in the same compartment as the CD-1 resident
mouse for either a cumulative total of 60 s physical attack or 10min
maximum, on days 1–15. Thereafter the two mice were placed one per
compartment and remained in sensory contact for 24 h. To prevent bite
wounds during attacks the lower incisors of CD-1 mice were trimmed
every third day. The timing of attacks and limiting them to 1min per
day maximum and the trimming of the incisor teeth of CD-1 mice
eliminates the deep bite wounds that otherwise occur (Golden et al.,
2011), and also markedly reduces the frequency of surface wounds
(Pryce and Fuchs, 2017). The number of surface wounds per experi-
ment was 1–2 in 2–4 of 12 CSS mice, as we reported in our original
description of this protocol (Azzinnari et al., 2014). The CSS – CD-1
mouse pairings were rotated so that each CSS mouse was placed in the
home cage of an unfamiliar CD-1 mouse each day. Each CSS mouse
displayed submissive behaviour and vocalization but continued to be
attacked by the CD-1 mouse; therefore, CSS mice experienced an un-
controllable social stressor. From the last attack session on day 15 until
the end of the experiment, each CSS mouse remained in the same di-
vided cage next to the same CD-1 mouse without further attacks.
Control (CON) mice remained in littermate pairs, the standard social
condition in our laboratory, and were handled daily.
2.4. Flow cytometry of splenocytes and brain mononuclear cells
In Expt 1 (Fig. S1), mice were anesthetized using isoﬂurane in-
halation, transcardially perfused with Ringer solution (Braun Medical),
and spleen and brain were dissected out. For isolation of splenocytes,
the spleen was minced in Roswell Park Memorial Institute (RPMI)
medium (5% foetal-calf serum) and digested for 20min at RT in Hanks'
balanced salt solution (HBSS) containing 50 μg/ml DNase I and 100 μg/
ml collagenase/dispase (Roche). The digested spleen was passed
through a 100 μl Nylon mesh (BD Biosciences), followed by lysis of
erythrocytes in ammonium-chloride-potassium (ACK) buﬀer. After a
ﬁnal resuspension in HBSS, cells were counted (using a Neubauer
chamber) and 5×106 splenocytes were stained for each spleen.
Mononuclear cells (MNCs) from entire brain were isolated as described
previously (Ferretti et al., 2016; Moransard et al., 2010): the brain was
chopped with a scalpel, and digested for 30min at 37 °C in HBSS con-
taining 50 μg/ml DNase I and 100 μg/ml collagenase/dispase (Roche).
The digested brain was passed through a 100 μl Nylon mesh, pelleted
and re-suspended in 30% Percoll (Sigma) in HBSS. Myelin debris was
removed via aspiration. The gradient was centrifuged at 29,000 g for
30min at 4 °C. The interphase containing MNCs was collected and
washed with HBSS.
For ﬂow cytometry of splenocytes and brain MNCs, each sample was
divided into two halves: one aliquot was used for extracellular staining
and the other for extracellular + intracellular staining. Intracellular
staining of cytokines was performed after a 4 h incubation with phorbol
myristate acetate (PMA, 50 ng/ml) and ionomycin (500 ng/mL). Flow
cytometry was conducted with a LSR II Fortessa (BD). Cells were re-
suspended in FACS buﬀer comprising 2% FCS, 10 mM EDTA and 0.01%
NaN3 in PBS. Fc receptors were blocked by incubation with anti-mouse
CD16/32 (BioLegend). The LIVE/DEAD® Fixable Aqua Dead Cell Stain
Kit (Molecular Probes) was used to exclude non-viable cells. For ex-
tracellular staining, the antibodies used were: CD45 (BD Biosciences),
CD11b (BD Biosciences), MHC II (BD Biosciences) and Ly6c
(Biolegend). For extracellular + intracellular staining, the antibodies
used were: CD45, CD11b, CD4 (Biolegend), Foxp3 (eBioscience), IL-17A
(BD Biosciences), CD8 (eBioscience), TNF-α (BD Biosciences) and IFN-γ
(BD Biosciences). Splenic immune cells were counted using a Neubauer
chamber, and the same number of cells per mouse was used for ana-
lysis. For counts of brain MNCs, ﬂuorescent Counting Beads were used
(Molecular Probes). Expression levels of proteins were estimated using
the geometric mean of ﬂuorescence intensity (MFI). FlowJo software
(Tree Star) was used for ﬂow cytometry data analysis.
2.5. ELISA for plasma inducible nitric oxide synthase (iNOS)
In Expt 2 (Fig. S1), mice were decapitated and trunk blood was
collected into EDTA-coated tubes (Microvette 500 K3E, Sarstedt) and
placed on ice. Tubes were centrifuged at 3000 rpm for 15min at 4 °C
and plasma aliquots were transferred to Protein LoBind tubes (Eppen-
dorf) and stored at −80 °C. Plasma iNOS was measured in duplicate
using a commercial ELISA kit (Mouse Inducible nitric oxide synthase
ELISA Kit, MyBioSource) according to the manufacturer's instructions.
2.6. Iba1 immunoperoxidase staining
In Expt 3 (Fig. S1), mice were deeply anesthetized with pento-
barbital and perfused transcardially with phosphate-buﬀered saline
(PBS, pH 7.4) and ﬁxative (4% paraformaldehyde (PFA) in PBS). Brains
were dissected out, post-ﬁxed overnight (o/n) in 4% PFA and cryo-
protected in 30% sucrose for 48 h, frozen on powdered dry ice and
stored at −80 °C until sectioning. Brains were sectioned coronally at
40 μm using a microtome (Zeiss), with sections collected in antifreeze
solution (15% glucose and 30% ethylene glycol in 50mM phosphate
buﬀer, pH 7.4) and stored at −20 °C. Sections including the VTA
(bregma −2.8 to −3.0mm) or NAcc (bregma 1.1–1.5 mm), 3–6 per
region/mouse, were identiﬁed referring to a mouse brain atlas
(Franklin and Paxinos, 2008). Free-ﬂoating sections were washed with
PBS, quenched with 3% H2O2 for 15min, blocked with 10% normal
serum and incubated o/n at 4 °C with a rabbit anti-Iba1 antibody
(1:1000; Wako Chemicals) followed by a 2 h RT incubation with a
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biotinylated goat anti-rabbit secondary antibody (1:500; Millipore).
Sections were then incubated with 1% avidin-biotin peroxidase com-
plex (Vectastain ABC kit, Vector) for 30min at RT. Labeling was vi-
sualized using diaminobenzidine (DAB) solution. Images were acquired
using a brightﬁeld microscope (Axiovert, Zeiss). Digital image analysis
(DIA) of Iba1 staining was conducted blind with respect to mouse
identity using the software ImageJ (NIH): the threshold for positive
staining was determined and used to calculate the percentage of the
area of each image that was Iba1-immunoreactive (IR) (Klaus et al.,
2016; Wohleb et al., 2011).
2.7. Real-time quantitative PCR (qPCR)
Mice were decapitated, and liver (Expt 2) or brain (Expt 4, Expt 8)
(Fig. S1) was dissected out and frozen on dry ice. For liver, total RNA
was isolated using Trizol (Ambion) according to the manufacturer's
instructions, and further digested with DNase I (Fermentas). Frozen
brains were sectioned coronally at 1.0mm intervals using a stainless-
steel brain matrix, and the VTA (−2.5 to −3.5 ± 0.2mm) or NAcc
(bregma 1.8 to 0.8 ± 0.2mm) was identiﬁed referring to a mouse
brain atlas (Franklin and Paxinos, 2008) and microdissected bilaterally
using a brain punch (∅=0.5mm for VTA and∅=1.0mm for NAcc)
(Azzinnari et al., 2014). Tissue biopsies per region were combined and
placed in 350 μl lysis RLT buﬀer (Qiagen) containing 1% β-mercap-
toethanol, and homogenized using a tissue lyser (Mixer-Mill 300,
Qiagen) with stainless steel beads (∅=5mm, Retsch). Total RNA was
isolated using the RNeasy Plus Micro Kit (Qiagen). The genes of interest
and the respective primers used are given in Table S1. RNA was reverse
transcribed using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). Quantitative gene expression analysis was per-
formed using SYBR green (Applied Biosystems) and a 7900HT Fast
Real-Time PCR System (Applied Biosystems). PCR cycle conditions
were: 2 min at 50 °C, 2min at 95 °C; 40 cycles: 15 s at 95 °C, 30 s at
60 °C, 30 s at 72 °C. A melting curve was run for each PCR plate.
Threshold cycle (Ct) values of the target gene were normalized to the Ct
values of the corresponding reference gene, using the ΔΔCt method
(Pfaﬄ et al., 2002). For liver genes the geometric mean of Ct values for
Hprt1 and Tbp was used as the normalization factor (NF), and for brain
genes Actb was used as the reference gene. Relative expression values
were log2-transformed for statistical analysis.
2.8. LC-MS/MS of the kynurenine pathway in NAcc and VTA
In Expt 5 (Fig. S1), mice were anesthetized and transcardially per-
fused with saline, decapitated, and the brain dissected out, frozen on
powdered dry-ice and stored at −80 °C. Frozen brains were sectioned
coronally at 1.0 mm intervals and the VTA and NAcc were micro-
dissected bilaterally. Tissue biopsies per region were combined,
weighed and stored at −80 °C pre- and post-transport and transported
on dry ice. Brain levels of tryptophan (TRP), kynurenine (KYN) and 3-
hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-OH-AA) and
quinolinic acid (QUIN) were measured by Brains Online using liquid
chromatography (LC) tandem mass spectrometry (MS/MS). Tissue le-
vels of 3-OH-AA and QUIN were below the lower limit of quantiﬁcation
(LLOQ) for all samples in both brain regions. Protein content of tissue
punches was measured using the Bradford method. Brain concentra-
tions of TRP, KYN and 3-HK are expressed as nmol or pmol/mg protein.
Absolute concentrations and the KYN/TRP ratio were calculated.
2.9. Dopamine receptor autoradiography
In Expt 6 (Fig. S1), mice were decapitated and the brains dissected
out, frozen on powdered dry ice, stored at −80 °C pre- and post-
transport and transported on dry ice. Frozen brains were sectioned
coronally at 20 μm and serial sections containing the VTA (bregma level
−3.0mm) or NAcc (bregma 1.8mm) were collected and mounted on
polysine coated slides, and stored at −80 °C prior to autoradiography;
for each region, two sections were used per mouse and receptor. Au-
toradiography for D1 receptor binding was conducted according to
(Dalton and Zavitsanou, 2011). Brieﬂy, sections were preincubated in
0.05M Tris-HCl buﬀer (pH 7.4) for 10min, and then incubated for 1 h
with 1 nM [3H]SCH-23390 (spec. act. 60 Ci/mmol, 1 mCi/ml, Perki-
nElmer, U.S.A.) in Tris-buﬀer at room temperature. Non-speciﬁc
binding was assessed in the presence of 1 μM unlabelled R(+)-SCH-
23390 (Sigma Aldrich, U.K.). Slides were rinsed 2x in ice-cold Tris
buﬀer. The method used for D2 receptor autoradiography is described
in (Leventopoulos et al., 2009). Brieﬂy, sections were pre-incubated in
0.05M Tris-HCl buﬀer (pH 7.6) for 20min, and then incubated for 1.5 h
with 2 nM [methoxy-3H]raclopride (spec. act. 85 Ci/mmol, 1 mCi/ml,
American Radiolabeled Chemicals, Inc., U.S.A.) in Tris-buﬀer at room
temperature. Non-speciﬁc binding was assessed using 1 μM unlabelled
raclopride (Sigma Aldrich, U.K.). For D1 and D2 receptors, air-dried
brain sections and 3H-microscale standards (Amersham Biosciences)
were apposed to tritium-sensitive BioMax MR hyperﬁlm (Kodak, U.K.)
for 6 weeks to generate autoradiograms, and tissue radioactivity was
then quantiﬁed by densitometry using an image analysis system
(MCID™, Version 7.0, Imaging Research Inc., Interfocus Ltd, Linton,
U.K.). Flat-ﬁeld correction and calibration of tritium standards were
applied to quantify tissue radioactivity in nCi/mg. VTA and NAcc re-
gions of interest were sampled in both the right and left hemispheres in
each section and the mean value per mouse was used for statistical
analysis; imperfect images with signs of tissue damage were excluded
from the analysis.
2.10. HPLC-ED of NAcc tissue dopamine and metabolites
In Expt 7 (Fig. S1), mice were decapitated and the brain dissected
out, frozen on powdered dry ice and stored at −80 °C. Frozen brains
were sectioned coronally at 1.0mm intervals and the NAcc was micro-
dissected bilaterally. The two biopsies were combined and weighed,
and homogenized using 250 μl ice-cooled perchloric acid (0.4 M). Ul-
trasonication was conducted for 5 s at 30% power (VibraCell,
VCX130PB, Sonics and Materials), followed by centrifugation at
16,000 g for 10min at 4 °C. The supernatant was passed through a
0.22 μm ﬁlter (Minisart RC4, Sartorius AG) and kept on ice until ana-
lysis. High performance liquid chromatography (HPLC) and electro-
chemical detection (ED) were conducted for DA and its major meta-
bolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid
(HVA), according to (Oeckl et al., 2012). Brieﬂy, isocratic separation of
DA was carried out with a reversed-phase C18 column (YMC-Pack ODS-
AQ, 100×2.1mm, S-3 μm, YMC Europe GmbH). The mobile phase
consisted of 1.7 mM 1-octanesulfonic acid sodium salt, 1.0 mM
Na2EDTA×2H2O, 8.0mM NaCl, 100mM NaH2PO4×2H2O (pH 3.8),
mixed with 9.3% acetonitrile; it was delivered at a ﬂow rate of 0.4ml/
min. For ED an electrochemical cell with a glassy carbon electrode and
an ISAAC Ag/AgCl reference electrode (VT-03, Antec) was used.
Homogenate (20 μl) was injected onto the HPLC system using an au-
tosampler (ASI-100T). Dopamine, DOPAC and HVA concentrations
were calculated using an external standard calibration and expressed as
ng/mg NAcc tissue.
2.11. Behavioural testing
2.11.1. Locomotor activity test for group allocation and after GBR 12909
In each of Expts 1–8, using an automated test apparatus (Multi
Conditioning System, TSE Systems (Pryce et al., 2012)), a 15-min motor
activity test in a novel arena was conducted and total activity was used
to counterbalance allocation of mice to CSS and CON groups (Azzinnari
et al., 2014). In Expt 8 (Fig. S1), on day 16 CSS and CON mice were
injected intra-peritoneally (i.p.) with either the dopamine transporter
(DAT) inhibitor GBR 12909 dihydrochloride (Sigma-Aldrich) at 6mg/
kg in physiological saline vehicle (VEH) or with VEH only. After
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returning to the home cage for 30min, mice were placed into an arena
for 2 h of activity measurement. This was the same arena as used for
baseline activity testing but now contained a central divider with an
opening (gate) through which mice could transfer from one side of the
arena to the other, to stimulate activity/exploration. The main measure
of interest was total locomotor activity (arbitrary units). Mice were then
returned to their home cage and activity was monitored continuously
for 24 h using a passive infrared sensor located above the cage (MP
Motion Sensor AMN12112, Panasonic) and connected to a RedLab re-
cording unit (1024HLS, Meilhaus Electronic). During home cage ac-
tivity monitoring, CON mice were separated from their cage mate using
the same dividers used to separate CSS and CD-1 mice; CON mice were
habituated to the divider for 2 h per day on days 13–14. On day 17,
after completion of the home-cage activity monitoring, mice were in-
jected with a second i.p. dose of GBR 12909 or VEH (same dose as on
day 16) and after 30min were decapitated and brains were processed
for NAcc RNA extraction (see Quantitative PCR assays).
2.11.2. Two-bottle saccharin test
In Expt 9 (Fig. S1), mice were habituated to 15ml capped poly-
propylene tubes from which the tip had been removed to enable
drinking (Cathomas et al., 2015). Two such tubes were attached adja-
cently to the cage lid each day at 08:00 h and removed at 16:00 h.
Amount drunk per tube was calculated based on weight. Since CON
mice were pair-housed, the liquid consumption per tube and cage was
calculated and adjusted for individual body weights, to obtain esti-
mated values for each mouse. On days −12 to −8 (baseline), mice
were presented with one tube containing water and one tube containing
0.15% (W/V) saccharin (as sodium salt hydrate, Sigma) solution, with
the left-right positioning of the two tubes alternated across days
(Cathomas et al., 2015). On the ﬁnal day of baseline measurements,
average saccharin consumption per mouse was 5.4 ± 1.4 g, average
water consumption was 0.15 ± 0.10 g, and average saccharin pre-
ference was 98.7 ± 0.5% (mean ± SD). The eﬀects of CSS on sac-
charin and water drinking and saccharin preference were tested in a
single test at day 16, between 08:00–16:00 h.
2.11.3. Operant reward tests
2.11.3.1. Operant apparatus. In Expt 10 (Fig. S1), training and testing
were conducted using operant chambers (TSE Systems) details of which
are given elsewhere (Bergamini et al., 2016a, 2016b; Ineichen et al.,
2012). Brieﬂy, nose-poke apertures detected mouse operant responses
via an infra-red beam; the position of the apertures relative to the
feeder port and the number of apertures used changed according to the
test (see below). Sucrose pellets (14mg, Dustless Precision Pellets,
BioServ) were delivered singly into the feeder port, signalled by a tone
from a speaker. Pellet retrieval was detected via infra-red beam.
2.11.3.2. Feeding protocols. Mice had ad libitum access to food until age
12 weeks. At week 11, for 5 days, daily body weight (BW) and daily
food intake were measured to obtain mean free-feeding (baseline)
values. Beginning at week 12 and continuing throughout operant
training, mice were food restricted to 90–95% of baseline BW to
ensure adequate motivation during operant training with sucrose
pellet reinforcement. For one week prior to and throughout the 15-
day CSS, mice were provided with suﬃcient standard diet to return to
and maintain 100% of baseline BW. As described previously, CSS mice
require more standard diet per day than CON mice to maintain this
target BW (Bergamini et al., 2016a). Post-CSS, for the learned non-
reward test (see below), mice were maintained at 95% baseline BW
with CSS mice again required more standard diet than CON mice.
Standard diet was provided in the home cage 2–3 h after operant
training/testing and was always fully consumed within the dark phase,
such that mice did not eat for about 12 h prior to operant testing.
2.11.3.3. Fixed-ratio 1 schedule of reinforcement (FR1) test and learned
non-reward (LNR) test. The ﬁxed-ratio 1 schedule of reinforcement
(FR1) test is a precursor test to the learned non-reward (LNR) test, and
the LNR test was used because it is sensitive to NAcc DA function, as
demonstrated by the eﬀects of pharmacological depletion of NAcc DA
using 6-hydroxydopamine (Bergamini et al., 2016b). The same operant
training was required for both tests. Through a series of conditioning
steps mice learned to: make an operant response (nosepoke) into the
feeder (trial initiation). This led to illumination of a stimulus aperture
in the opposite, stimulus wall; an operant response (nosepoke) into the
stimulus aperture (stimulus response) led to a 1-s tone and
simultaneous delivery of one sucrose pellet into the feeder; the mouse
returned to the feeder wall and retrieved the pellet (collect pellet
latency), which initiated a 2.5 s time out, after which the next trial
could be initiated. At the ﬁnal training stage, mice had 10 s maximum
for each trial initiation and 6 s maximum for each stimulus response;
omission of either response resulted in a 5 s timeout prior to the next
trial. A session comprised either 70 trials or 30min, whichever occurred
ﬁrst. The criterion for training completion was 2 sessions of 70 trials in
which≥49 pellets were obtained. Thereafter two further daily sessions
were conducted, and the mean number of pellets obtained in these four
sessions was used to counterbalance allocation of mice to CSS and CON
groups.
The FR1 test consisted of the same conditions as used at the ﬁnal
stage of training (Fig. S2) and was conducted at CSS day 8 with mice
maintained at 100% baseline BW. Measures of interest were: omissions
to initiate trials, omissions to emit stimulus responses in initiated trials,
total pellets earned, and session duration. LNR testing began at day 16
and was conducted until mice had attained criterion on both test stages
(see below). Across this period CSS mice were maintained in the same
cage and next to the same CD-1 mouse. The LNR test was based on that
described by (Nilsson et al., 2012) and applied in Bergamini et al.
(2016b). The protocol was the same as used for the FR1 test except that
there were now three spatial locations (left, middle, right) for apertures
in the stimulus wall and two of these were in use at each test stage (Fig.
S2). The ﬁrst stage was a two-choice spatial discrimination (SD): fol-
lowing trial initiation, the mouse had to choose between two stimulus
apertures whilst a blank panel occupied the third location (Fig. S2). A
response in the correct stimulus aperture led to tone and sucrose pellet
delivery in the feeder port and an incorrect response led to a 5 s
timeout. Mice had 10 s maximum for each trial initiation and 6 s
maximum for the choice response. The SD stage consisted of 70 trials
divided into seven 10-trial blocks; SD learning criterion was nine cor-
rect choice responses within any 10-trial block. If a mouse did not attain
criterion the SD test was repeated on the next day until criterion was
attained. On the day after attaining SD criterion, the learned non-re-
ward (LNR) stage was run: the SD correct stimulus was removed and
replaced by the blank panel, the SD incorrect stimulus was now the
correct stimulus, and the blank panel was replaced by the new incorrect
stimulus (Fig. S2). The mouse must be suﬃciently interested in reward
to respond at the previously incorrect (non-rewarded) stimulus, in the
absence of the possibility to perseverate at the previously correct sti-
mulus. Number of trials, time allowed for trial initiation and choice
responding, and learning criterion (9 correct choice responses within a
10-trial block) were the same as for the SD stage; if the mouse did not
attain LNR test criterion the test was repeated on the next day until
criterion was attained. Measures of interest for each of the SD and LNR
test stages were the total number (cumulative across test days) of oc-
currences until attaining criterion of: omissions to initiate trials, omis-
sions to emit choice responses in initiated trials, incorrect choice re-
sponses in initiated trials, total errors (i.e. the sum of the previous three
error types), and correct choice responses in initiated trials. Mice re-
quired a total of 3–13 daily tests to attain criterion on both test stages. It
is relevant that 6-hydroxydopamine NAcc DA depletion was without
eﬀect on behaviour at the SD stage and increased omissions to initiate
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trials and incorrect choice responses at the LNR stage (Bergamini et al.,
2016b).
2.12. Statistical analysis
Statistical analysis of CSS eﬀects was conducted using SPSS (version
20, SPSS Inc., Chicago IL, USA). With the exception of Expt 10 an un-
paired t-test or analysis of variance (ANOVA) was used. Where appro-
priate, ANOVA post hoc testing was conducted using the Bonferroni
procedure. Analysis of covariance (ANCOVA) was used in Expt 10 (FR1
test) with % baseline body weight as covariate. Statistical signiﬁcance
was set at p≤ 0.05. Where an estimate of variance is given this is the
standard deviation (SD).
3. Results
3.1. CSS induces peripheral and VTA-NAcc immune-inﬂammation
activation
Firstly, CSS eﬀects on spleen and whole-brain immune-cell status
were investigated using ﬂow cytometry (Fig. 1, Expt 1). For spleno-
cytes, relative to controls, CSS mice had fewer lymphocytes (CD45+/
CD11b−) (t(10) = 3.5, p < 0.007, Fig. 1A and B) and more myeloid
cells (CD45+/CD11b+) (t(10) = 2.3, p < 0.05, Fig. 1A, C). Within the
latter (Fig. 1D) both granulocytes (SSChi/Ly6Cint) (t(10) = 2.6,
p < 0.03, Fig. 1E) and inﬂammatory monocytes (SSClo/Ly6Chi)
(t(10) = 3.2, p < 0.02, Fig. 1F) were more abundant in spleens of CSS
than CON mice. Using mean ﬂuorescence intensity (MFI) to quantify
activation markers, major histocompatibility complex II (MHC II) sur-
face expression on myeloid cells was lower in CSS mice (t(10) = 3.9,
p < 0.003, Fig. 1G). As revealed by intracellular staining and MFI,
myeloid-cell expression of TNF-α (t(9)= 2.7, p < 0.03, Fig. 1H) and
IFN-γ (t(9) = 4.0, p < 0.003, Fig. 1I) was higher in CSS than CON mice.
As stated above, CSS mice had less splenic lymphocytes than CON mice:
in terms of T-cell type (Fig. 2A), CSS had no eﬀect on total numbers of
CD4+ T cells (p= 0.26, Fig. 2B) or cytotoxic CD8+ T cells (p= 0.79,
Fig. 2C). Within CD4+ T cells there was no CSS eﬀect on number of Th1
cells (CD4+/IFN-γ+) (p=0.41, Fig. S3A and B) or Treg cells (CD4+/
Foxp3+) (p= 0.53, Figs. S3C and D). However, CSS mice had more
Th17 cells (CD4+/IL17A+) than CON mice (t(9)= 3.8, p < 0.005,
Fig. 2D and E). Given that the reduced total lymphocyte count in CSS
mice was not accounted for by an overall reduction in T cell popula-
tions, future studies will need to investigate B cell populations.
We next investigated CSS eﬀects on liver expression of genes
Fig. 1. Eﬀects of CSS on splenic leukocytes at day 16 assessed using ﬂow cytometry (Expt 1). Spleens were processed from 6 CSS and 6 CON mice. A) FACS dot plots for gating of
lymphocytes and myeloid cells based on CD45 and CD11b staining, in representative CON and CSS mice. B) Cell counts for lymphocytes (CD45+/CD11b−). C) Cell counts for myeloid
cells (CD45+/CD11b+). D) FACS dot plots for total myeloid cells gated based on SSC and Ly6C staining, in representative CON and CSS mice. E) Cell counts for granulocytes (SSChi/
Ly6Cint). F) Cell counts for inﬂammatory monocytes (SSClo/Ly6Chi). G - I) Expression levels of activation markers in splenic myeloid cells (CD45+/CD11b+); marker expression is
measured as the geometric mean of ﬂuorescence intensity (MFI). G) MHC II, H) TNF-α, I) IFN-γ. In H) and I) the data point for one CSS mouse was excluded because of a methodological
problem with the intracellular staining. p values were obtained in unpaired t-tests. CD45, cluster of diﬀerentiation 45; CD11b, cluster of diﬀerentiation 11b; SSC, side scatter of cells;
Ly6C, lymphocyte antigen 6C.
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encoding enzymes in the kynurenine (KYN) pathway of tryptophan
catabolism (Fig. 3A) using qPCR (Fig. S1, Expt 2). CSS mice had higher
liver expression of Tdo1 (t(10) = 2.4, p < 0.04), Ido2 (t(10)= 2.6,
p < 0.03), Tdo2 (t(10)= 2.6, p < 0.03), Kynu (t(10) = 2.3, p < 0.05)
and 3-Haao (t(10) = 3.4, p < 0.007), and a borderline non-signiﬁcant
increase in Kmo (p= 0.08) (Fig. 3B). As expected, liver expression of
Ido1 was barely detectable in both CON and CSS mice i.e. Ct > 36–37
(Dai and Zhu, 2010; Fuertig et al., 2016). Given that activated myeloid
cells (Expt 1) and up-regulation of the KYN pathway (Expt 2) are both
associated with increased oxidative stress, we measured blood plasma
levels of iNOS in the latter mice using ELISA (Expt 2): plasma iNOS was
increased in CSS compared to CON mice (t(10) = 2.6, p < 0.03)
(Fig. 3C).
Regarding CSS eﬀects on brain immune status, in the same mice
used to study spleen leukocytes (Fig. S1, Expt 1), we isolated and
analysed mononuclear cells from whole brain. There was no CSS eﬀect
on total numbers of microglia (CD11b+/CD45int) (p= 0.55, Fig. 4A
and B), inﬁltrating myeloid cells (CD11b+/CD45hi) (p= 0.70, Fig. 4A,
C), or lymphocytes (CD11b−/CD45+) (p=0.13, data not shown). To
assess brain region-speciﬁc eﬀects of CSS on microglia, we quantiﬁed
microglia marker Iba1 expression in the VTA and NAcc (Fig. S1, Expt
3). In the VTA a higher % area was Iba1-immunoreactive in CSS com-
pared with CON mice (t(13) =−2.8, p < 0.02, Fig. 4D and E). There
was no eﬀect of CSS on Iba1 staining in the NAcc (CON
1.55% ± 0.34%, CSS 1.52% ± 0.25%, p=0.82; data not shown). In
the next experiment (Fig. S1, Expt 4) the VTA was microdissected and
mRNA expression of the microglia/macrophage marker Cd11b was
measured using qPCR: CSS mice had higher VTA Cd11b expression than
Fig. 2. Eﬀects of CSS on splenic T cells at day 16 assessed using ﬂow cytometry (Expt 1). Spleens were processed from 6 CSS and 6 CON mice (same mice as in Fig. 1). A) FACS dot plots
for gating of CD4+ and CD8+ T cells in representative CON and CSS mice. B) Cell counts for CD4+ T cells. C) Cell counts for CD8+ T cells. D) FACS dot plots for gating of Th17 cells
(CD4+/IL-17A+) in representative CON and CSS mice. E) Cell counts for Th17 cells. In B), C) and E) the data point for one CSS mouse was excluded because of a methodological problem
with the intracellular staining. p value was obtained in an unpaired t-test. CD4, CD8, cluster of diﬀerentiation 4, 8; IL-17A, interleukin-17A; Th17, T helper 17.
Fig. 3. Eﬀects of CSS on liver kynurenine-pathway enzyme gene expression and on plasma iNOS levels at day 16 (Expt 2). Liver and blood-plasma were obtained from 6 CSS and 6 CON
mice. A) Metabolic steps in the kynurenine (KYN) pathway showing enzymes measured: tryptophan metabolism to N-formylkynurenine is catalysed by indoleamine 2,3-dioxygenase 1
and 2 (IDO1, IDO2) and tryptophan 2,3-dioxygenase 1 and 2 (TDO1, TDO2), and N-formylkynurenine is degraded by formamidase to kynurenine (KYN). KYN conversion to 3-hydro-
xykynurenine (3-HK) is catalysed by kynurenine 3-monooxygenase (KMO), and 3-HK to 3-hydroxyanthranilic acid (3-HANA) by kynureninase (KYNU). 3-hydroxyanthranilic acid 3,4-
dioxygenase (3-HAO) converts 3-HANA to 2-amino-3-carboxymuconic-6-semialdehyde, which rearranges to form quinolinic acid (QA). B) Comparison of liver mRNA expression of the
gene encoding each of the above enzymes, as measured using qPCR, in CON and CSS mice. C) Plasma concentration (International Units per litre plasma) of inducible nitric oxide synthase
measured using ELISA. p values were obtained in unpaired t-tests.
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CON mice (t(20) =−2.7, p < 0.02, Fig. 4F).
Building on the evidence that CSS leads to increased liver expression
of KYN pathway genes, as well as previous evidence that CSS increases
KYN and 3-HK levels in blood and brain (Fuertig et al., 2016), we mi-
crodissected the VTA and NAcc for determination of tryptophan (TRP),
KYN and 3-HK using LC-MS/MS (Fig. S1, Expt 5): In VTA, CSS led to a
trend level increase in KYN (t(16) = 1.9, p < 0.07) and CSS mice had a
higher KYN/TRP ratio, a marker of KYN pathway activation
(t(16) = 2.5, p < 0.03, Table 1). In NAcc, CSS led to a trend level in-
crease in TRP (t(19) = 1.8, p < 0.09) and to higher levels of KYN
(t(19) = 2.2, p < 0.03, Table 1). There was no eﬀect of CSS on 3-HK
titres in VTA (p=0.39) or NAcc (p= 0.34) (Table 1).
3.2. CSS leads to blunted functioning of the mesolimbic dopamine system
Having obtained evidence that CSS leads to activation of microglia
Fig. 4. Eﬀects of CSS on brain measures of immune status at day 16 (Expts 1, 3 and 4). Expt 1: Fresh brains were obtained from 6 CSS and 6 CON mice (same mice as in Figs. 1 and 2). A)
FACS dot plots from representative CON and CSS mice for mononuclear cells from whole brain tissue showing gating of lymphocytes (CD11b−/CD45+) and CD11b+ cells (left-hand dot
plots); within CD11b+ cells, CD45 staining was used to gate microglia (CD45int) and brain-inﬁltrating myeloid cells (CD45hi) (right-hand dot plots). B) Cell counts for microglia. C) Cell
counts for myeloid cells. Expt 3: Perfused brains were obtained from 7 CSS and 8 CON mice were sectioned and immunostained for the microglia marker Iba1. D) Representative images of
Iba1 staining in the ventral tegmental area (VTA, demarcated with dashed white lines) from a CON mouse and a CSS mouse. E) Percentage Iba1+ immunoreactive (IR) area in the VTA.
Expt 4: Fresh ﬁxed brains were obtained from 12 CSS and 10 CON mice. F) Comparison of VTA expression of CD11b mRNA measured using qPCR. p values were obtained in unpaired t-
tests.
Table 1
Eﬀects of CSS on the kynurenine pathway activity in VTA and NAcc.
Compound VTA NAcc
TRP CON 0.86 ± 0.46 0.92 ± 0.66
(nmol/mg protein) CSS 1.04 ± 0.6 1.46 ± 0.73#
KYN CON 2.13 ± 0.82 2.57 ± 1.82
(pmol/mg protein) CSS 4.03 ± 2.96# 4.76 ± 2.62∗
KYN/TRP CON 2.72 ± 0.79 3.05 ± 0.82
(*1000) CSS 3.91 ± 1.21∗ 3.24 ± 0.57
3-HK CON 1.15 ± 0.36 1.57 ± 1.38
(pmol/mg protein) CSS 1.38 ± 0.69 2.05 ± 0.95
Concentrations are mean ± SD; VTA: CON n=10, CSS n= 8; NAcc: CON n=10, CSS
n= 11.
*p < 0.05, #p < 0.10.
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and the kynurenine pathway in VTA and of the kynurenine pathway in
NAcc, we investigated for CSS eﬀects on the status and functioning of
the VTA-NAcc DA system. In the same cohort in which CSS mice had
higher VTA Cd11b expression, we measured VTA expression of several
genes essential to DA synthesis or signalling, namely tyrosine hydro-
xylase (Th), vesicular monoamine transporter 2 (Vmat2), dopamine
transporter (Dat) and dopamine receptor 2 (Drd2) (Fig. S1, Expt 4). In
the case of Vmat2, VTA expression was higher in CSS mice
(t(20) =−2.1, p < 0.05) (Fig. 5A). For each of the other genes, whilst
mean mRNA expression was higher in CSS than CON mice there was no
signiﬁcant eﬀect of CSS: Th (p= 0.14), Dat (p= 0.29), Drd2 (p= 0.12)
(Fig. 5A). We then used autoradiography to determine D1 receptor
binding in VTA and NAcc and D2 receptor binding in NAcc (Fig. S1,
Expt 6). In VTA, D1 receptor binding was higher in CSS than in CON
mice (t(13)= 3.59, p < 0.004, Fig. 5B). There was no eﬀect of CSS on
D1 receptor binding in NAcc (CON 232 ± 25 nCi/mg, CSS 242 ± 20,
p=0.40, data not shown), or on D2 receptor binding in NAcc (CON
22 ± 3 nCi/mg, CSS 22 ± 3, p=0.98, data not shown). In the next
experiment, HPLC-ED was used to investigate CSS eﬀects on NAcc
tissue levels of DA and its metabolites (Fig. S1, Expt 7). There was no
signiﬁcant eﬀect of CSS on absolute levels of NAcc DA (CON
4.77 ± 1.15 ng/mg tissue, CSS 4.77 ± 1.33, p=0.99), DOPAC (CON
0.53 ± 0.12, CSS 0.44 ± 0.14, p=0.15) or HVA (CON 0.46 ± 0.21,
CSS 0.42 ± 0.17, p= 0.66) (data not shown). However, the ratio
DOPAC/DA, which provides the major measure of DA turnover, was
reduced in the NAcc in CSS relative to CON mice (t(19) = 2.2, p < 0.05,
Fig. 5C). There was no CSS eﬀect on the HVA/DA ratio (p=0.57,
Fig. 5D).
Building on the ex vivo evidence for reduced mesolimbic DA func-
tioning in CSS mice, we investigated for in vivo and further ex vivo
evidence using acute challenge with the dopamine transporter (DAT)
inhibitor GBR 12909 (Fig. S1, Expt 8). On day 16, mice were injected
i.p. with GBR 12909 or vehicle (VEH) and assessed in terms of eﬀects on
arena locomotor activity (Fig. 5E). In a 2 Stress (CON, CSS) x 2 Drug
(VEH, GBR 12909) ANOVA, there were main eﬀects of Stress (F(1,
21)= 7.4, p < 0.02) and Drug (F(1, 21)= 34.7, p < 0.0005) and a
Fig. 5. Eﬀects of CSS on the mesolimbic dopamine system (Expts 4, 6, 7 and 8). Expt 4: Fresh frozen brains were obtained from 12 CSS and 10 CON mice (same mice as in Fig. 3F). A)
Comparison of VTA expression of genes encoding proteins for dopamine synthesis and signalling at day 16, as measured using qPCR: tyrosine hydroxylase (Th), dopamine receptor 2
(Drd2), dopamine transporter (Dat), vesicular monoamine transporter 2 (Vmat2). Expt 6: Fresh frozen brains were obtained from 8 CSS and 8 CON mice at day 16 for DA D1 and D2
receptor binding using autoradiography. B) VTA D1 receptor binding, and representative computer-enhanced autoradiograms of [3H]SCH-23390 total binding in coronal sections
including VTA from a CON and CSS mouse. The colour scale calibrates signal intensity against tritium standards. p value was obtained in an unpaired t-test. Expt 7: Fresh frozen brains
were obtained from 10 CSS and 11 CON mice at day 16 for quantiﬁcation of NAcc levels of dopamine (DA) and its metabolites DOPAC and HVA. B) NAcc DOPAC/DA ratio. C) NAcc HVA/
DA ratio. p values were obtained in unpaired t-tests. Expt 8: Behavioural and NAcc immediate-early gene readouts for eﬀects of CSS and DAT inhibitor GBR 12909 (6 mg/kg i.p.) at days
16–17. CSS and CON mice received either GBR 12909 or saline vehicle (VEH) on each of days 16 and 17. E) Day 16 total locomotor activity in an arena during 2 h, starting 30 min post-
injection. Values are mean + SD. p values are for Stress X Drug ANOVA followed by post hoc Bonferonni tests. F) Day 16–17 home cage activity beginning 2.5 h post-injection and
measured across the remaining active (dark) phase (i.e. 13.00–19.00 h) and subsequent inactive (light) phase (i.e. 19.00–7.00 h). Activity was sampled at 1 min intervals and average
hourly values calculated. *p < 0.05, **p < 0.01 for Stress × Time interaction in repeated measures ANOVA followed by time-speciﬁc CSS vs. CON post hoc Bonferonni tests. G) Day 17
NAcc c-fos expression (mean ± SD) in fresh ﬁxed brains collected 30min after a second injection, measured using qPCR. H) Day 17 NAcc Arc expression (mean ± SD) measured under
the same conditions as in F. p values were obtained in 2-way ANOVA followed by post hoc Bonferroni tests. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the Web version of this article.)
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trend to a Stress×Drug interaction eﬀect (F(1, 21) = 3.7, p < 0.07): in
post hoc pairwise tests, activity was similar in CON-VEH and CSS-VEH
mice, both CON-GBR mice (p < 0.001) and CSS-GBR mice (p < 0.01)
were more active than their respective VEH groups, and CSS-GBR mice
were less active than CON-GBR mice (p < 0.004). Thereafter, mice
were returned to their home cage and activity was measured from
13:00 h to 07:00 h the following day. In a 2 Stress x 2 Drug x 19 Time-
block (Hour) repeated measures ANOVA, there was a Stress×Time
interaction (F(18, 378)= 1.9, p < 0.05, Fig. 5F), with post hoc analysis
identifying lower activity in CSS compared with CON mice across
16:00–20:00 h i.e. end of the active-dark phase (Fig. 5F). On day 17,
mice received a second GBR 12909 or VEH challenge and were sacri-
ﬁced after 30min; brains were collected for qPCR analysis of the im-
mediate-early genes c-fos and Arc in the NAcc. For c-fos expression there
were main eﬀects of Stress (F(1, 21)= 6.19, p < 0.03) and Drug (F(1,
21) = 7.44, p < 0.02) without interaction (p= 0.57) (Fig. 5G): c-fos
expression was lower in CSS compared with CON mice, and higher in
GBR 12909 compared with VEH mice, such that mean c-fos expression
was lowest in CSS-VEH mice. For Arc expression, there was no Stress
eﬀect (p= 0.40) and a main eﬀect of Drug (F(1, 21)= 6.06, p < 0.02)
with Arc expression higher in GBR 12909 compared with VEH mice
(Fig. 5H). Therefore, the data suggest that GBR 12909 challenge re-
vealed blunted DA functioning in CSS mice in terms of locomotor ac-
tivity and NAcc c-fos expression.
3.3. CSS reduces operant behaviour for sucrose reward
In the ﬁnal two experiments, CSS eﬀects on behaviour directed at
gustatory reward were investigated, ﬁrstly in terms of consumption of
freely-available sweet-tasting reward in a two-bottle saccharin versus
water test (Fig. S1, Expt 9). On day 16, there was no eﬀect of CSS on the
high absolute amount of saccharin drinking (CON 5.2 ± 2.1 g, CSS
5.3 ± 1.1 g, p= 0.87, data not shown); whilst all mice drank relatively
little water, CSS mice drank more than CON mice (CON 0.08 ± 0.00 g,
CSS 0.21 ± 0.02 g, t(18) =−2.35, p < 0.04). Primarily due to the
latter, CSS mice exhibited a lower saccharin preference at trend level
(CON 98.1% ± 0.04%, CSS 96.1% ± 0.04%, t(18) = 1.96, p= 0.07).
CSS eﬀects on operant behaviour for sucrose-pellet reward were
then investigated (Fig. S1, Expt 10). For operant training, mice were
standard-diet restricted so that body weight (BW) was 90–95% of
baseline. At the ﬁnal training stage mice had a limited interval of 10 s to
make an operant response at the feeder to initiate the trial and a limited
interval of 6 s to make an operant response at the single operant sti-
mulus to trigger pellet delivery back at the feeder. When all mice were
trained, CSS/CON were carried out and suﬃcient standard diet was
provided to maintain each mouse at 100% baseline BW: during these
15-days CON mice weighed 100 ± 3% baseline BW and CSS mice were
mildly higher at 103 ± 3% baseline BW (t(25) =−3.08, p < 0.005,
data not shown); the absolute BW was similar in CON (26.5 ± 1.4 g)
and CSS mice (26.9 ± 1.2 g) (p= 0.38). At CSS day 8, mice were
studied in the ﬁxed-ratio 1 (FR1) test with parameters the same as at
the ﬁnal training stage. To control for any eﬀect of % baseline BW, it
was included as covariate in ANCOVA for CSS eﬀects. Operant re-
sponding for reward was reduced in CSS compared with CON mice in
terms of: higher number of omissions to initiate trials (F(1, 24)= 5.70,
p < 0.03, Fig. 6A), fewer pellets earned (F(1, 24)= 5.29, p < 0.04,
Fig. 6C), and greater session duration (F(1, 24)= 7.55, p < 0.02,
Fig. 6D). CSS was without eﬀect on omissions to emit a stimulus re-
sponse in initiated trials (p= 0.67, Fig. 6B) and on latency to collect
pellets (CON 1.46 ± 0.68 s, CSS 2.17 ± 1.43 s, p= 0.13). Inter-in-
dividual variability was greater in CSS than CON mice on some mea-
sures (Fig. 6A, C).
Beginning on day 16, these mice were investigated in the two stages
of the learned non-reward (LNR) test. This comprised a spatial dis-
crimination (SD) stage with one rewarded and one non-rewarded op-
erant stimulus, followed by a LNR stage with the rewarded operant
stimulus removed, the previously non-rewarded operant stimulus now
the rewarded operant stimulus, and a novel non-rewarded operant
stimulus (Fig. S2). For SD and LNR stages, each daily test consisted of
70 trials divided into 10-trial blocks, the criterion for learning was nine
correct responses within any one block, the same stage was repeated the
next day if criterion was not attained, and for each measure the total
number (cumulative across test days) of occurrences until attaining
criterion was used for analysis. Mice were maintained at 95% baseline
BW across the testing period: actual BW was 97 ± 4% baseline in CON
mice and 95 ± 2% baseline in CSS mice (p=0.23, data not shown). At
the SD stage, mice required 1–5 daily tests to attain the learning cri-
terion (CON 1–4, CSS 1–5). There was no eﬀect of CSS on any measure:
omissions to initiate trials (CON 24 ± 25, CSS 33 ± 39, p=0.53),
omissions to emit choice responses in initiated trials (CON 17 ± 12,
CSS 27 ± 28, p=0.25), incorrect choice responses (CON 24 ± 19,
CSS 19 ± 22, p=0.52), total errors (CON 65 ± 52, CSS 79 ± 79,
p=0.62), and correct choice responses (CON 46 ± 22, CSS 62 ± 34,
p=0.18) (data not shown). At the LNR stage, mice required 1–8 daily
tests to attain the learning criterion (CON 1–4, CSS 1–8). Relative to
CON mice, CSS mice exhibited deﬁcits in reward-directed behaviour in
terms of: higher number of omissions to initiate trials (t(14) =−2.4,
p < 0.04, Fig. 6E), higher incorrect choice responses in initiated trials
i.e. avoiding the previously non-rewarded operant stimulus (t
(24)=−2.2, p < 0.04, Fig. 6G), and higher total errors (t
(18)=−2.4, p < 0.05, Fig. 6H). CSS and CON mice behaved similarly
in terms of omissions to emit choice responses in initiated trials
(p= 0.16, Fig. 6F) and correct choice responses (CON 57 ± 22, CSS
43 ± 27, p=0.19). Inter-individual variability was greater in CSS
than CON mice on most LNR measures.
4. Discussion
The present mouse study demonstrates that chronic social stress
leads to a constellation of: immune-inﬂammation activation in the
periphery, immune activation in the VTA-NAcc DA pathway, reduced
VTA-NAcc DA pathway functioning, and reduced NAcc DA-dependent
reward-directed behaviour. To our knowledge this is the ﬁrst demon-
stration of the co-occurrence of each of these altered system states
within one stress model. Evidence of co-occurrence is of course not
evidence of causality. However, the overall ﬁnding that these altered
states do co-occur following stress is both an essential pre-requisite and
provides major justiﬁcation for proposing a causal pathway linking
them (e.g. (Felger and Treadway, 2017)). Fig. 7 illustrates the current
ﬁndings with respect to each of the stress-induced system states; it also
presents these system states within the hypothesized causal pathway,
from stress activation of the immune system to altered mesolimbic DA
function and resultant impaired reward processing. Here we discuss the
ﬁndings within each of the stress-induced states in terms of how these
expand on and complement existing knowledge, and also present some
speciﬁc hypotheses linking adjacent states in the pathway. This mouse
model can now be utilised to investigate cause-eﬀect pathophysiolo-
gical mechanisms at the interfaces between immunity, dopamine re-
ward circuitry and behaviour, with the major aim of identifying mo-
lecular targets for treatment of stress-related reward psychopathologies.
Building on previous evidence that CSS mice exhibit splenomegaly
(Azzinnari et al., 2014; Fuertig et al., 2016) this study demonstrates
that CSS leads to increased myeloid splenocytes, including granulocytes
and inﬂammatory monocytes. Mouse repeated social defeat also in-
creases splenic granulocytes and monocytes (Avitsur et al., 2002). The
splenic myeloid cells of CSS mice had higher expression of the proin-
ﬂammatory cytokines TNF-α and IFN-γ, suggesting that they contribute
to the increased blood levels of these cytokines reported for CSS mice
(Azzinnari et al., 2014; Fuertig et al., 2016). Splenic myeloid cell sur-
face MHC II expression was reduced in CSS mice; higher levels of in-
tracellular MHC II promote an innate immune response (Liu et al.,
2011) and it will be important to determine whether CSS leads to
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intracellular accumulation of MHC II. Regarding eﬀects on the adaptive
immune system, splenic total lymphocytes were reduced in CSS com-
pared with CON mice. This reduction was not attributable to splenic
CD4+ or CD8+ T cells and might reﬂect less B cells; future experiments
will need to test for this. Despite the overall decrease in lymphocytes
and lack of eﬀect on total CD4+ T cells, CSS mice had more splenic T
helper 17 cells than did CON mice. Th17 cells secrete proinﬂammatory
cytokines, including IL-17A, IL-17F, IL-22, IL-6 and TNF-α (Kimura and
Kishimoto, 2010). Numerical imbalance between Th17 and Treg cells
occurs in mice exposed to chronic or acute stress (Beurel et al., 2013;
Hong et al., 2012), and chronic social stress leads to increased T-cell
eﬀector functions in the periphery (Schmidt et al., 2010). Peripheral or
CNS infusion of Th17 cells leads to depression-relevant behaviour in
mice, although reward-directed behaviours were not studied (Beurel
Fig. 6. Eﬀects of CSS on reward-directed beha-
viour in operant tests (Expt 10). At CSS day 8, 15
CSS and 12 CON mice were tested in a ﬁxed ratio
1 schedule (FR1) test with a time limit of 10 s to
initiate each trial and 6 s to emit an operant re-
sponse at a single stimulus. A) Omissions to in-
itiate trials. B) Omissions to emit stimulus re-
sponse in initiated trials. C) Pellets earned. D)
Session duration. p values were obtained in
ANCOVA with % baseline body weight included
as covariate. Beginning at day 16, CSS and CON
mice were tested in the learned non-reward (LNR)
test that comprised a time limit of 10 s to initiate
each trial and 6 s to emit an operant choice re-
sponse. At the simple discrimination stage there
was no signiﬁcant eﬀect of CSS. At the LNR stage
the rewarded operant stimulus was removed, the
previously non-rewarded operant stimulus was
now the rewarded operant stimulus, and a novel
non-rewarded operant stimulus was introduced
(see Fig. S2): E) Omissions to initiate trials. F)
Omissions to emit choice response on initiated
trials. G) Incorrect choice responses. H) Total er-
rors. p values were obtained in unpaired t-tests.
One CON mouse was a statistical outlier and was
removed from the dataset.
Fig. 7. Diagram depicting each of the system states that was impacted by 15-day chronic social stress and a hypothesized causal pathway, from stress activation of the immune system to
altered mesolimbic DA function and resultant impaired reward processing. The solid arrows linking chronic social stress with each separate system depict the causal relationships
identiﬁed in this study. The dashed arrow linking each pair of systems depicts the causal relationship hypothesized to exist between them which can be investigated in the present model.
For each system state the factors that were studied and demonstrated to be aﬀected by CSS are indicated, with either a quantitative increase (↑) or decrease (↓) in the factor in CSS
compared with CON mice. BBB=blood-brain barrier and denotes that peripheral-to-brain immune activation would require BBB passage in the case of some mediating pathways. CSS
eﬀects on factors marked with an asterisk were not analysed in this study and the eﬀects were demonstrated in previous studies.
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et al., 2013). Th17 cells are important in autoimmune diseases
(Aranami and Yamamura, 2008), including multiple sclerosis which is
highly comorbid with depression (Slyepchenko et al., 2016). It has been
proposed that depression is caused by stress-induced Th17 cell-medi-
ated autoimmunity in some patients (Chen et al., 2011; Slyepchenko
et al., 2016). Whilst it activated splenic myeloid cells, in the same mice
CSS was without eﬀect on whole-brain microglia, macrophages or
lymphocytes. Previous mouse studies have demonstrated that stress
induces a generalized activation of microglia (Gerecke et al., 2013; Nair
and Bonneau, 2006; Wohleb et al., 2012), and indeed monocyte traf-
ﬁcking to the brain (Wohleb et al., 2014). One possible explanation for
the current absence of CSS eﬀects on whole-brain microglia/macro-
phage levels is that stress-induced activation occurs in a speciﬁc time
window (Kreisel et al., 2014; Nair and Bonneau, 2006). We then in-
vestigated CSS eﬀects on microglia activation in the regions of interest:
Iba1 immunoreactivity was increased in VTA and not in NAcc, and
increased expression of the macrophage/microglia gene Cd11b in VTA
corroborated this ﬁnding. We also measured Iba1 immunoreactivity in
the stress-sensitive regions of the amygdala and prefrontal cortex and
there was no increase in CSS mice (data not shown). Activation of Iba1
in the VTA and other regions, e.g. medial prefrontal cortex, has been
reported for mice exposed to 10-day chronic social defeat (Tanaka
et al., 2012). Future studies will need to investigate the time course of
CSS eﬀects on microglia activation as well as brain monocytes and T
cells, and also whether the present evidence that VTA is more suscep-
tible than NAcc to CSS-induced microglia activation can be sub-
stantiated. The latter will also need to investigate CSS eﬀects on Iba1-
based microglia morphology including cell body to cell size ratio
(Hovens et al., 2014).
A further important stress-responsive peripheral-to-CNS immune
pathway is tryptophan-kynurenine (KYN) catabolism: Increases in TNF-
α, IFN-γ and IL-6 activate indoleamine 2,3-dioxygenase (IDO1) and
tryptophan 2,3-dioxygenase (TDO2) expression in immune and other
cells, promoting tryptophan-KYN catabolism in periphery and brain
(Campbell et al., 2014; Haroon et al., 2016; Schwarcz et al., 2012).
Peripheral activation of the kynurenine pathway occurs in depression
and other stress-related psychiatric disorders (Haroon et al., 2012; Kim
et al., 2012; Savitz et al., 2015a, 2015b; Steiner et al., 2011; Sublette
et al., 2011). We reported that CSS leads to increased blood levels of
KYN, 3-HK and kynurenic acid, and to increased KYN and 3-HK levels in
amygdala, hippocampus and prefrontal cortex (Fuertig et al., 2016).
Chronic mild stress in mice induced activation of KYN-pathway en-
zymes in skeletal muscle and liver and increases in plasma KYN and
brain 3-HK (Agudelo et al., 2014). Here, CSS led to increased liver
expression of genes encoding KYN-pathway enzymes, namely Tdo1,
Ido2, Tdo2, Kynu and 3-Haao (Ido1 has negligible expression in liver
(Dai and Zhu, 2010; Fuertig et al., 2016)). Future study will need to
determine whether the stimulatory eﬀect of CSD on liver kynurenine
pathway enzyme transcription also leads to increased expression of the
respective enzymes per se. In VTA, CSS mice had a higher KYN/TRP
ratio, and in NAcc they had higher absolute KYN levels, whilst 3-HK
was unaﬀected in these regions of interest. Given that microglia were
activated in VTA of CSS mice, both peripheral and local synthesis could
contribute to the increase in KYN-pathway activity in this region
(Fuertig et al., 2016; Schwarcz et al., 2012). Inducible nitric oxide
synthase (iNOS), the synthase responsible for catalysing the production
of nitric oxide in the context of immune regulation, was higher in the
plasma of CSS mice; these were the same mice in which liver expression
of KYN-pathway enzymes was up-regulated. Synthesis of iNOS is acti-
vated by both pro-inﬂammatory cytokines (Sheng et al., 2011) and
kynurenines (Colin-Gonzalez et al., 2013), peripheral levels of both of
which are increased by CSS (Azzinnari et al., 2014; Fuertig et al., 2016).
Nitric oxide and kynurenines promote oxidative stress as accumulation
of reactive oxygen species (ROS), to regulate immune responses (Wink
et al., 2011). However, in the VTA, high ROS levels contribute to oxi-
dation and deactivation of the enzyme cofactor for DA synthesis,
tetrahydrobiopterin (Bove et al., 2005; Felger and Miller, 2012; Felger
and Treadway, 2017). Future studies with the CSS model will in-
vestigate causal involvement of oxidative stress in CSS-induced VTA-
NAcc DA pathway changes.
The current assessment of CSS eﬀects on the VTA-NAcc DA pathway
included VTA expression of certain genes encoding DA synthesis and
transport proteins. Expression of the genes encoding tyrosine hydro-
xylase, the DA transporter and DA receptor 2 was not aﬀected con-
sistently by CSS. CSS did lead to increased VTA gene expression of
vesicular monoamine transporter 2 (Vmat2). Given that CSS led to
immune activation in VTA, increased Vmat2 expression might reﬂect
compensatory up-regulation of DA axonal transport. Furthermore, CSS
mice exhibited increased VTA D1 receptor binding. In the VTA, D1
receptors are expressed at the terminals of axons of glutamate neurons
(e.g. prefrontal cortex), GABA neurons (e.g. NAcc, ventral pallidum)
and VTA GABA interneurons, where they bind DA to regulate local
release of glutamate and GABA at synapses with VTA DA neurons (Lu
et al., 1997). Stimulation of VTA D1 receptors facilitates release of
glutamate that excites DA neurons (Rahman and McBride, 2000), but
also facilitates release of GABA that inhibits DA neurons (Klitenick
et al., 1992). Local VTA microinjection of D1 receptor antagonist in-
hibits reward sensitivity (Galaj et al., 2014). Therefore, depending on
which VTA neurons acquire the increased D1 receptor binding in CSS
mice, the CSS-induced increase in VTA D1 receptor binding could
constitute a neuroplastic compensation for attenuated DA release in
terminal areas. The VTA DA neurons project to NAcc (core and shell),
prefrontal cortex, amygdala and hippocampus. In NAcc, whilst there
was no CSS eﬀect on absolute tissue levels of DA and its metabolites
DOPAC and HVA, CSS mice had lower NAcc DA turnover in terms of a
lower DOPAC/DA ratio. A previous mouse study reported a higher
DOPAC/DA ratio in NAcc and mPFC after a single social defeat and a
lower ratio after 10-day chronic social defeat (Tanaka et al., 2012).
Reduced DA turnover in the basal ganglia has been reported for de-
pression (Bowden et al., 1997). There was no CSS eﬀect on D1 or D2
receptor binding in NAcc.
We further investigated CSS eﬀects on DA function using acute
challenge with the selective DA transporter blocker/reuptake inhibitor
GBR 12909. In mice, GBR 12909 increases extracellular DA levels in
NAcc and dorsal striatum (Abdallah et al., 2009), induces hyper-loco-
motion (Irifune et al., 1995) and up-regulates NAcc expression of im-
mediate-early genes c-fos and Arc (Iadarola et al., 1993). NAcc DA de-
pletion reduces responsiveness to psychostimulants (Koob et al., 1978).
Whilst CSS and CON mice did not diﬀer in basal locomotor activity in
an arena, GBR 12909 challenge resulted in attenuated hyper-locomo-
tion in CSS compared with CON mice. GBR 12909 hypo-sensitivity of
CSS mice could be due to higher DA transporter function; however,
there was no CSS eﬀect on VTA Dat expression. Another possibility is
down-regulation of post-synaptic DA signalling in striatal neurons.
Whilst there was no CSS eﬀect on NAcc D1 or D2 receptor binding,
NAcc expression of the immediate early gene c-fos (although not Arc)
was down-regulated in CSS mice, both in basal state and following GBR
12909. These c-fos ﬁndings are in line with previous studies demon-
strating that stress attenuates the acute increase in CNS c-fos expression
induced by novel stimulus exposure (Ons et al., 2010; Ostrander et al.,
2006; Stone et al., 2007). Future studies will investigate CSS eﬀects on
NAcc expression of genes and proteins involved in DA post-synaptic
signalling; down-regulated expression of genes important in post-sy-
naptic DA signalling has already been demonstrated for amygdala of
CSS mice (Azzinnari et al., 2014).
To investigate CSS eﬀects on reward-directed behaviour we used
tests of reward consumption and, in particular, eﬀortful and dis-
criminatory operant behaviour. In a previous study, CSS led to reduced
operant responding for sucrose pellets on a progressive ratio schedule
indicating attenuated eﬀortful motivation, and to reduced responding
at the correct stimulus in a reversal learning test indicating attenuated
reward expectancy (Bergamini et al., 2016a). In the two-bottle test,
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several studies report decreased preference for sweet solution relative
to water in chronic social defeat mice (Covington et al., 2009;
Henriques-Alves and Queiroz, 2015; Krishnan et al., 2007). The re-
duced saccharin preference observed in CSS mice was at trend level and
due to increased water consumption, with the latter probably due to
their increased feeding (Bergamini et al., 2016a). Interestingly, in de-
pressed patients, reduced consummatory pleasure as measured by the
Sweet taste test is not reduced relative to controls (Dichter et al., 2010;
Treadway, 2016; Treadway and Zald, 2011). The FR1 test was con-
ducted at CSS day 8: already at this time-point reward-directed beha-
viour was reduced in CSS mice, with the major deﬁcit being increased
number of omissions to initiate trials within the limited time interval.
This could reﬂect attenuated reward valuation and/or psychomotor
slowing in CSS mice; the absence of a CSS eﬀect on reward-collect la-
tency makes the former more likely. In the learned non-reward (LNR)
test, CSS was without eﬀect at the simple discrimination stage, in-
dicating that reward valuation was intact under moderate food depri-
vation. At the subsequent LNR stage, CSS mice made more omissions to
initiate trials and more incorrect-choice responses. The increase in in-
correct choice responding indicates that CSS mice have attenuated:
reward expectancy which impairs their learning of the new contingency
between stimulus and reward, and/or reward valuation which reduces
their responding to the previously non-rewarded and now rewarded
stimulus. In a set-shifting operant task used to assess the learned non-
reward eﬀect in humans, depressed patients also exhibited reduced
responding to previously non-rewarded and now rewarded stimuli
compared with healthy controls (Michopoulos et al., 2006). Dopamine
signalling modulates reward valuation and expectancy in rodents
(Berridge and Kringelbach, 2013). CSS actually recapitulated the eﬀects
of NAcc DA depletion with 6-hydroxydopamine, which also led to more
omissions to initiate trials and incorrect-choice responses speciﬁc to the
LNR stage (Bergamini et al., 2016b). Depressed patients exhibit lower
anticipatory reward valuation (Sherdell et al., 2012), including under
eﬀortful conditions (Hershenberg et al., 2016; Treadway et al., 2012;
Yang et al., 2014), and this is associated with reduced activity in the
ventral striatum (Arrondo et al., 2015). In rodents, acute inﬂammatory
challenge (e.g. IL-1β, LPS, CD40 agonist antibody) induces sickness
followed by a period of reduced consumption of and preference for
sweet reward under freely available conditions (Biesmans et al., 2013;
Cathomas et al., 2015). In addition, similarly to CSS mice and depressed
humans, inﬂammation leads to reduced anticipatory reward valuation
and particularly under eﬀortful conditions (Cathomas et al., 2015;
Nunes et al., 2014; Vichaya et al., 2014). Some CSS mice exhibited si-
milar scores to CON mice in the behavioural tests. We consider this to
be primarily due to CSS-induced changes in appetite regulators, e.g.
lower plasma leptin levels (Bergamini et al., 2016a), that were only
partially compensated by feeding more standard diet to CSS than CON
mice. Such changes would counteract the impact of CSS attenuation of
VTA-NAcc-DA pathway function in some mice. Tests that measure ef-
fortful responding for sucrose when standard diet is freely available in
the operant chamber (Salamone et al., 2016; Vichaya et al., 2014) will
probably identify more consistent eﬀects of CSS on reward-directed
behaviour.
Using the manipulation of 10-day chronic social defeat (CSD) some
laboratories divide mice into susceptible versus resilient sub-groups
based on subsequent passive avoidance or active approach, respec-
tively, of the aggressor mouse strain (Krishnan et al., 2007). It has been
reported that a high plasma level of interleukin 6 (IL-6) after 1 day of
stress defeat provides a biomarker for subsequent susceptibility, plasma
IL-6 level remains chronically elevated after CSD (Hodes et al., 2014),
and IL-6 passage from blood to brain contributes to loss of sucrose
preference and reduced mobility in the forced swim test in CSD-sus-
ceptible mice (Menard et al., 2017). It has not been reported whether
susceptible and resilient mice diﬀer in their behaviour during the daily
10-min attack sessions. In rat, using a 5-day repeated resident-intruder
paradigm resulted in individuals with short versus long latency to
assume a defeat body posture, and the former group had higher levels
of post-stress brain IL-1β mRNA and reduced sucrose preference (Wood
et al., 2015). In line with our previous studies with 15-day CSS, in the
present study we have used an inclusive experimental design in terms of
not separating CSS mice into susceptible versus resilient sub-groups.
With this design and sample sizes of 10–12 CSS versus CON mice we
have demonstrated robust and reproducible eﬀects of CSS on depres-
sion-relevant behaviour, brain functional connectivity and metabolism,
and blood immune-inﬂammatory markers ((Azzinnari et al., 2014;
Bergamini et al., 2016a; Fuertig et al., 2016; Grandjean et al., 2016);
present study). We observe each CSS attack: as described in our original
report on this manipulation, any back-ﬁghting by BL/6 mice with ag-
gressor CD-1 mice is restricted to days 1–5 and thereafter all mice ex-
hibit a defeat/submissive body posture and emit submissive vocaliza-
tions during each attack session (Azzinnari et al., 2014). Plasma levels
of each of TNF-α, INF-γ and IL-6 are increased on day 16 in CSD mice
(Azzinnari et al., 2014; Fuertig et al., 2016). In future studies it will be
interesting to investigate whether the latency to exhibit submissive
behaviour and/or basal plasma cytokine levels predict the extent of
post-CSD eﬀects within the CSD group, in addition to the overall CSD
eﬀects relative to CON mice.
In summary, this mouse study provides comprehensive evidence
that chronic social stress leads to a constellation of immune-in-
ﬂammation activation in the periphery, immune activation in the VTA-
NAcc DA pathway, reduced VTA-NAcc DA pathway functioning, and
reduced NAcc DA-dependent reward-directed behaviour. This model
can now be applied to test causal hypotheses on pathophysiological
mechanisms via which immune activation impacts on dopamine func-
tioning in the mesolimbic pathway, with the aim of identifying targets
for treatment of stress-related psychopathologies of reward processing.
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